Eukaryotic cell membrane and intracellular organelles

Eukaryotic cell membranes and intracellular organelles represent the complex network of lipid bilayers and specialized compartments that define eukaryotic cell architecture. The plasma membrane functions as a selective barrier and a hub for signal transduction, while organelles like the mitochondria and endoplasmic reticulum manage energy metabolism and protein homeostasis (Alberts et al., Molecular Biology of the Cell). In pharmacology, these structures are typically viewed as the environment for specific molecular targets rather than targets themselves. However, certain therapeutic classes, such as general anesthetics and some antifungal agents, exert their effects by modulating membrane fluidity or disrupting lipid integrity (Nature Reviews Drug Discovery). Because these structures are ubiquitous across all human tissues, targeting them directly often leads to significant safety concerns, including non-specific cytotoxicity and organ damage (StatPearls). Furthermore, intracellular organelles like the lysosome are involved in the sequestration of drugs, which can affect pharmacokinetics and lead to lysosomal storage disorders (PubMed). The integrity of these membranes is vital for maintaining cellular gradients and preventing the release of pro-apoptotic factors from the mitochondria (NIH). Consequently, while not traditional targets, their physiological state is a critical factor in drug development and safety assessment.

Other names

Plasma membraneCytoplasmic membraneEndomembrane systemCellular compartmentsOrganelle membranes

Modulation of membrane fluidity, disruption of lipid bilayer integrity, or inhibition of organelle-specific metabolic processes.